Abnormal expression of matrix metalloproteinase-9 (MMP9) correlates with clinical course in Chinese patients with endometrial cancer

Disease Markers

Volumn 32, Issue 5, 2012, Pages 321-327

  Yu, Fang ^a,c   Jiang, Qingping ^c   Zhou, Ying ^b   Yang, Zhen ^b   Yu, Xiaoli ^b   Wang, Hao ^b   Liu, Zhen ^c   Wang, Lijing ^a   Fang, Weiyi ^a,b   Guo, Suiqun ^a  

^a THE THIRD AFFILIATED HOSPITAL OF SOUTHERN MEDICAL UNIVERSITY   (China)

^b SOUTHERN MEDICAL UNIVERSITY   (China)

^c GUANGZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Chinese patients; endometrial cancer; Matrix metalloproteinase 9

Indexed keywords

GELATINASE B;

ADULT; ARTICLE; CANCER INVASION; CANCER PROGNOSIS; CANCER SURVIVAL; CLINICAL FEATURE; CYTOPLASM; DISEASE COURSE; ENDOMETRIUM CANCER; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 84861494137     PISSN: 02780240     EISSN: 18758630     Source Type: Journal    
DOI: 10.3233/DMA-2011-0886     Document Type: Article

References (25)

1. F. Amant, P. Moerman, P. Neven, D. Timmerman, E. Van Limbergen, and I. Vergote, Endometrial cancer. Lancet 366 (2005), 491-505. (Pubitemid 41111699)
2. A. Jemal, R. C. Tiwari, T. Murray, A. Ghafoor, A. Samuels, E. Ward, E. J. Feuer and M. J. Thun, Cancer statistics, 2004. CA Cancer J Clin 54 (2004), 8-29.
3. R. Fridman, M. Toth, D. Pena and S. Mobashery, Activation of progelatinase B (MMP-9) by gelatinase A (MMP-2). Cancer Res 55 (1995), 2548-2555.
4. J. R. Backstrom and Z. A. Tokes, The 84-kDa form of human matrix metalloproteinase-9 degrades substance P and gelatin. J Neurochem 64 (1995), 1312-1318.
5. M. Iurlaro, G. Loverro, A. Vacca, G. Cormio, D. Ribatti, M. Minischetti, R. Ria, M. Bruno and L. Selvaggi, Angiogenesis extent and expression of matrix metalloproteinase-2 and-9 correlate with upgrading and myometrial invasion in endome-trial carcinoma. Eur J Clin Invest 29 (1999) 793-801. (Pubitemid 29425521)
6. K. Aglund, M. Rauvala, U. Puistola, T. Angstrom, T. Turpeenniemi-Hujanen, B. Zackrisson and U. Stendahl, Gelatinases A and B (MMP-2 and MMP-9) in endometrial cancer-MMP-9 correlates to the grade and the stage. Gynecologic Oncology 94 (2004), 699-704. (Pubitemid 39194463)
7. L. A. Di Nezza, A. Misajon, J. Zhang, T. Jobling, M. A. Quinn, A. G. Ostor, G. Nie, A. Lopata and L. A. Salamonsen, Presence of active gelatinases in endometrial carcinoma and correlation of matrix metalloproteinase expression with increasing tumor grade and invasion. Cancer 94 (2002), 1466-1475. (Pubitemid 34213290)
8. M. Honkavuori, A. Talvensaari-Mattila, Y. Soini, T. Turpeenniemi-Hujanen and M. Santala, MMP-2 expression associates with CA 125 and clinical course in endometrial carcinoma. Gynecol Oncol 104 (2007), 217-221. (Pubitemid 46054133)
9. W. Guo, G. Chen, C. Zhu and H. Wang, [Expression of matrix metalloproteinase-2, 9 and it's tissue inhibitor-1, 2 in endome-trial carcinoma]. Zhonghua Fu Chan Ke Za Zhi 37 (2002), 604-607.
10. C. Amalinei, C. Cianga, R. Balan, P. Cianga, S. Giusca and I. D. Caruntu, Immunohistochemical analysis of steroid receptors, proliferation markers, apoptosis related molecules, and gelatinases in non-neoplastic and neoplastic endometrium. Ann Anat 193 (2011), 43-55.
11. R. Masunaga, H. Kohno, D. K. Dhar, S. Ohno, M. Shibakita, S. Kinugasa, H. Yoshimura, M. Tachibana, H. Kubota and N. Nagasue, Cyclooxygenase-2 expression correlates with tumor neovascularization and prognosis in human colorectal carcinoma patients. Clin Cancer Res 6 (2000), 4064-4068.
12. Z. Liu, L. Li, Z. Yang, W. Luo, X. Li, H. Yang, K. Yao, B. Wu, and W. Fang, Increased expression of MMP9 is correlated with poor prognosis of nasopharyngeal carcinoma. BMC Cancer 10 (2010), 270.
13. P. G. Rose, Endometrial carcinoma. N Engl J Med 335 (1996), 640-649. (Pubitemid 26277956)
14. O. Graesslin, A. Cortez, R. Fauvet, M. Lorenzato, P. Birem-baut and E. Darai, Metalloproteinase-2,-7 and-9 and tissue inhibitor of metalloproteinase-1 and-2 expression in normal, hyperplastic and neoplastic endometrium: a clinical-pathological correlation study. Ann Oncol 17 (2006), 637-645.
15. S. M. Laird, C. F. Dalton, M. A. Okon, R. A. Bunning, R. Marshall, and T. C. Li, Metalloproteinases and tissue inhibitor of metalloproteinase 1 (TIMP-1) in endometrial flushings from pre-and post-menopausal women and from women with en-dometrial adenocarcinoma. J Reprod Fertil 115 (1999), 225-232.
16. L. F. Lin, C. H. Chuang, C. F. Li, C. C. Liao, C. P. Cheng, T. L. Cheng, M. R. Shen, J. T. Tseng, W. C. Chang, W. H. Lee and J. M. Wang, ZBRK1 acts as a metastatic suppressor by directly regulating MMP9 in cervical cancer. Cancer Res 70 (2010), 192-201.
17. M. Loesch, H. Y. Zhi, S. W. Hou, X. M. Qi, R. S. Li, Z. Basir, T. Iftner, A. Cuenda and G. Chen, p38gamma MAPK cooperates with c-Jun in trans-activating matrix metalloproteinase 9. J Biol Chem 285 (2010), 15149-15158.
18. R. Bendardaf, A. Buhmeida, M. Hilska, M. Laato, S. Syrjanen, K. Syrjanen, Y. Collan and S. Pyrhonen, MMP-9 (gelatinase B) expression is associated with disease-free survival and disease-specific survival in colorectal cancer patients. Cancer Invest 28 (2010), 38-43.
19. Z. S. Zhao, Y. Y. Wang, Z. Y. Ye and H. Q. Tao, Prognostic value of tumor-related molecular expression in gastric carcinoma. Pathol Oncol Res 15 (2009), 589-596.
20. M. Tian, Y. Z. Cui, G. H. Song, M. J. Zong, X. Y. Zhou, Y. Chen, and J. X. Han, Proteomic analysis identifies MMP-9, DJ-1 and A1BG as overexpressed proteins in pancreatic juice from pancreatic ductal adenocarcinoma patients. BMC Cancer 8 (2008), 241.
21. X. Provatopoulou, A. Gounaris, E. Kalogera, F. Zagouri, I. Flessas, E. Goussetis, A. Nonni, I. Papassotiriou and G. Zografos, Circulating levels of matrix metalloproteinase-9 (MMP-9), neutrophil gelatinase-associated lipocalin (NGAL) and their complex MMP-9/NGAL in breast cancer disease. BMC Cancer 9 (2009), 390.
22. B. P. Patel, S. V. Shah, S. N. Shukla, P. M. Shah and P. S. Patel, Clinical significance of MMP-2 and MMP-9 in patients with oral cancer. Head Neck 29 (2007), 564-572. (Pubitemid 47324773)
23. K. Sakata, M. Someya, M. Omatsu, H. Asanuma, T. Hasegawa, S. Ichimiya, M. Hareyama and T. Himi, The enhanced expression of the matrix metalloproteinase 9 in nasal NK/T-cell lymphoma. BMC Cancer 7 (2007), 229.
24. M. H. Friedberg, M. J. Glantz, M. S. Klempner, B. F. Cole and G. Perides, Specific matrix metalloproteinase profiles in the cerebrospinal fluid correlated with the presence of malignant astrocytomas, brain metastases, and carcinomatous meningitis. Cancer 82 (1998), 923-930. (Pubitemid 28104173)
25. Y. Inoue, K. Abe, K. Obata, T. Yoshioka, G. Ohmura, K. Doh, K. Yamamoto, H. Hoshiai and K. Noda, Immunohistochemical studies on matrix metalloproteinase-9 (MMP-9) and type-IV collagen in endometrial carcinoma. J Obstet Gynaecol Res 23 (1997), 139-145. (Pubitemid 27220052)